Literature DB >> 22273435

Analysis of patients' preferences: direct assessment and discrete-choice experiment in therapy of adults with attention-deficit hyperactivity disorder.

Axel C Mühlbacher1, Matthias Nübling.   

Abstract

BACKGROUND: : Attention-deficit hyperactivity disorder (ADHD) is a complex neuropsychiatric disorder that affects children and young people, as well as adults. Since ADHD does not produce specific organic characteristics, behavior and preferences are crucial to diagnosis and treatment. Comprehensive therapy concepts should take full account of the needs of the patients.
OBJECTIVE: : To document therapy attributes that are important from the adults' perspective and to analyze findings from two different valuation approaches used in the same survey.
METHODS: : A self-administered survey measuring attitudes and preferences was conducted in Germany in 2009 (n = 329). Adult patients (aged ≥18 years) were recruited from all over Germany, with the help of patient advocacy organizations. Attitudes were measured and analyzed using a classic rating scale in 5-point Likert format. Discrete-choice experiment (DCE) scenarios were developed using a fractional factorial design and results were analyzed using random effects logit models.
RESULTS: : The aspect of highest importance for the respondents was that social function (job, studies, friendships) was not impaired (coefficient 2.115; standard error 0.111). The next most important in the view of the respondents was achievement of behavioral changes through treatment (coefficient 1.755; standard error 0.110). The 'drug intake' aspect was not important in the attitude component rating and not significant in the DCE.
CONCLUSIONS: : The primary goal of ADHD treatment is by no means the alleviation of core symptoms. Instead, therapy should help enable patients to set and achieve their own objectives. Treatment should enable patients to organize their social participation in everyday life.

Entities:  

Year:  2010        PMID: 22273435     DOI: 10.2165/11584640-000000000-000009

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  31 in total

Review 1.  Healthy-years equivalent: wounded but not yet dead.

Authors:  A Brett Hauber
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2009-06       Impact factor: 2.217

2.  Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms.

Authors:  F Reed Johnson; A Brett Hauber; Semra Ozdemir
Journal:  Value Health       Date:  2009 Jan-Feb       Impact factor: 5.725

3.  Using conjoint analysis to assess women's preferences for miscarriage management.

Authors:  M Ryan; J Hughes
Journal:  Health Econ       Date:  1997 May-Jun       Impact factor: 3.046

4.  The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder.

Authors:  Russell A Barkley; Mariellen Fischer; Lori Smallish; Kenneth Fletcher
Journal:  J Abnorm Psychol       Date:  2002-05

Review 5.  Attention-deficit/hyperactivity disorder in adults: an overview.

Authors:  S V Faraone; J Biederman; T Spencer; T Wilens; L J Seidman; E Mick; A E Doyle
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

6.  Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance.

Authors:  Tim Kendall; Eric Taylor; Alejandra Perez; Clare Taylor
Journal:  BMJ       Date:  2008-09-24

7.  Providing information to parents of children with mental health problems: a discrete choice conjoint analysis of professional preferences.

Authors:  Charles E Cunningham; Ken Deal; Heather Rimas; Yvonne Chen; Don H Buchanan; Kathie Sdao-Jarvie
Journal:  J Abnorm Child Psychol       Date:  2009-11

8.  Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Challenges in diagnosing adults with ADHD.

Authors:  Russell A Barkley
Journal:  J Clin Psychiatry       Date:  2008-12       Impact factor: 4.384

10.  Best--worst scaling: What it can do for health care research and how to do it.

Authors:  Terry N Flynn; Jordan J Louviere; Tim J Peters; Joanna Coast
Journal:  J Health Econ       Date:  2006-05-16       Impact factor: 3.883

View more
  6 in total

Review 1.  A descriptive review on methods to prioritize outcomes in a health care context.

Authors:  Inger M Janssen; Ansgar Gerhardus; Milly A Schröer-Günther; Fülöp Scheibler
Journal:  Health Expect       Date:  2014-08-25       Impact factor: 3.377

Review 2.  Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.

Authors:  Nicole K Schatz; Gregory A Fabiano; Charles E Cunningham; Susan dosReis; Daniel A Waschbusch; Stephanie Jerome; Kellina Lupas; Karen L Morris
Journal:  Patient       Date:  2015-12       Impact factor: 3.883

3.  Examining Parents' Preferences for Group and Individual Parent Training for Children with ADHD Symptoms.

Authors:  Frances A Wymbs; Charles E Cunningham; Yvonne Chen; Heather M Rimas; Ken Deal; Daniel A Waschbusch; William E Pelham
Journal:  J Clin Child Adolesc Psychol       Date:  2015-02-20

4.  Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis.

Authors:  Susan dosReis; Alex Park; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; Ellen M Janssen; John F P Bridges
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-12-19       Impact factor: 2.576

Review 5.  Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Kim Boesen; Asger Sand Paludan-Müller; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2022-02-24

6.  Eliciting preferences for continuing medication among adult patients and parents of children with attention-deficit hyperactivity disorder.

Authors:  Muhammad Umair Khan; Camila Balbontin; Michiel C J Bliemer; Parisa Aslani
Journal:  Health Expect       Date:  2022-03-10       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.